A matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells

Journal of Visualized Experiments

Volumn , Issue 55, 2011, Pages

  Francescone, Ralph A ^a   Faibish, Michael ^a   Shao, Rong ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Cancer biology; Endothelial; In vitro; Issue 55; Matrigel; Tube formation; Tumor; Vascular

Indexed keywords

EID: 80053903548     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3040     Document Type: Article

References (17)

1. Shao, R. & Guo, X. Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis. Biochemical & Biophysical Research Communications. 321, 788-94 (2004).
2. Ribeiro, M.J., et al. Hemostatic properties of the SV-40 transfected human microvascular endothelial cell line (HMEC-1). A representative in vitro model for microvascular endothelium. Thromb Res. 79, 153-61 (1995).
3. Ades, E.W., et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol. 99, 683-90 (1992).
4. Shao, R., et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Molecular & Cellular Biology. 24, 3992-4003 (2004).
5. Shao, R., et al. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene. 28, 4456-68 (2009).
6. Basu, G.D., et al. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Research. 8, R69 (2006).
7. Scavelli, C., et al. Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene. 27, 663-74 (2008).
8. El Hallani, S., et al. A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain. 133, 973-82.
9. Maniotis, A.J., et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. American Journal of Pathology. 155, 739-52 (1999).
10. Hendrix, M.J., Seftor, E.A., Hess, A.R., & Seftor, R.E. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nature Reviews Cancer. 3, 411-21 (2003).
11. Folberg, R., et al. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns. American Journal of Pathology. 169, 1376-89 (2006).
12. Liu, C., et al. Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer Research. 62, 5470-5 (2002).
13. Sood, A.K., et al. The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy. Cancer Biology & Therapy. 1, 661-4 (2002).
14. Shirakawa, K., et al. Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Research. 62, 560-6 (2002).
15. Ruf, W., et al. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Research. 63, 5381-9 (2003).
16. Seftor, R.E., et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Research. 61, 6322-7 (2001).
17. Shirakawa, K., et al. Vasculogenic mimicry and pseudo-comedo formation in breast cancer. International Journal of Cancer. 99, 821-8 (2002).